TSX Delisting Review for Response Biomedical Corporation (RBM)



    TORONTO, Oct. 15 /CNW/ - DELISTING REVIEW - Response Biomedical
Corporation (the "Company") - TSX is reviewing the common shares of the
Company (Symbol: RBM) with respect to meeting the continued listing
requirements. The Company has been granted 120 days in which to regain
compliance with these requirements, pursuant to the Remedial Review Process.

    
    About TMX Group (TSX-X)
    -----------------------
    

    TMX Group's key subsidiaries operate cash and derivative markets for
multiple asset classes including equities, fixed income and energy. Toronto
Stock Exchange, TSX Venture Exchange, Montreal Exchange, Natural Gas Exchange,
Shorcan, Equicom and other TMX Group companies provide trading markets,
clearing facilities, data products and other services to the global financial
community who access Canada's capital markets. TMX Group is headquartered in
Toronto with offices in Montreal, Calgary and Vancouver. For more information
about TMX Group, visit our website at www.tsx.com.




For further information:

For further information: Corporate Communications, TMX Group Inc., Toll
Free 1-888-873-8392, info@tsx.com


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890